Abstract

Objective: Early post-op outcomes for a novel glaucoma drainage device-the PAUL® glaucoma implant(PGI).
Methods: Retrospective evaluation post PGI surgery with 6-24 months follow-up. Primary outcome included surgical success defined as IOP of 5-18 mmHg or at least 20% reduction & qualified success (with or without IOP-lowering drops) at 6, 12,18 and 24 months.
Results: 26 eyes had preop IOP (mean ± SD) of 32.80 ± 10.76 mmHg, falling to 15.28 ± 4.88 mmHg at 6 months, 14.2 ± 5.13 mmHg at 12 months and 14.16 ± 5.53 at 2 years. Reduction of medication from 4.23± 0.71 to 0.92 ± 1.26 post op. (p value <0.0001).11 required IOP lowering drops post-op. Complete success of 61.53% at 6 months, 55% at 12 months, 54.50% at 18 months & 33.33% at 2 years was noted. Qualified success was at 88.46% at 6, 90% at12 & 100% at 18 months & 83.33% at 2 years.
Conclusion: This study presents a safe surgical technique, which significantly reduces IOP and number of medications with minimal complications.